The FDA has approved Susvimo (ranibizumab injection) for the treatment of patients with diabetic macular edema.
Patients with diabetic macular edema previously treated with a ranibizumab biosimilar in India experience comparable safety ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback